Effect of reduced glutathione in combination with sodium dimercaptosulphonate in the treatment of neurological Wilson‘s disease
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 4
Abstract
"<b>Objective</b> To evaluate the effectiveness and safety of reduced glutathione (rGSH) in combination with sodium dimercaptosulphonate (DMPS) for neurological Wilson’s disease (NWD), and to explore the effect of the combined treatment on oxidative stress levels. <b>Methods</b> Retrospective analysis of clinical data of 118 NWD patients who received rGSH combined with DMPS (observation group, n=62) or DMPS monotherapy (control group, n=56) at the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine from May 2020 to March 2022. Clinical data such as age, gender, clinical outcome, adverse effects, modified Young scale score, white blood cells, platelets, ceruloplasmin (CER), aspartate aminotransferase (AST), alanine aminotransferase (ALT), superoxide dismutase (SOD) and malondialdehyde (MDA) were collected and statistically analysed. <b>Results</b> Of the 62 NWD patients in the observation group, neurological symptoms improved in 46 cases and remained stable in 15 cases, while worsened in 1 case. Of the 56 NWD patients in the control group, neurological symptoms improved in 31 cases and remained stable in 18 cases, while worsened in 7 cases. The improvement of neurological symptoms in the observation group was better than that in the control group (U=2.381, P=0.017). The modified Young scale score was significantly decreased in both groups (P<0.05), and that in the observation group was lower compared to the control group (P<0.05). The levels of white blood cell, platelet, and CER remained stable in both groups (P>0.05). The combination treatment greatly facilitated 24-hour urinary copper excretion, and improved liver function (AST, ALT) and anti-oxidative stress levels (SOD, MDA) (P<0.05). Similar adverse reactions occurred in both groups (χ<sup>2</sup>=0.102, P>0.05). <b>Conclusion</b> Compared to DMPS monotherapy, rGSH plus DMPS for NWD patients can effectively ameliorate neurological symptoms, enhance urinary copper excretion and improve anti-oxidative stress levels with a high safety."
Authors and Affiliations
GAO Yannan, ZHANG Jing, TANG Lulu, YANG Wenming
Research progress on the pathogenesis and treatment of cervical spondylotic myelopathy
Cervical spondylotic myelopathy (CSM) is the most serious subtype of cervical spondylosis, which is the main cause of spinal cord dysfunction in middle-aged and elderly people, and the pathogenesis of this CSM is complex...
Diagnostic value of AFP, CEA and HSP90a in primary liver cancer based on the prediction model
Objective To construct a predictive model to analyze the diagnostic value of serum alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), heat shock protein 90a (Hsp90a) for primary liver cancer (PHC). Methods A retr...
Research progress of lung cancer complicated with pulmonary embolism
Pulmonary embolism and deep venous thrombosis are collectively referred to as venous thromboembolism, while pulmonary embolism is generally caused by deep venous thrombosis, which has the characteristics of sudden and mo...
Clinical efficacy of ultrasound-guided acupotomy combined with joint mobilization surgery in treatment of frozen shoulder
<b>Objective</b> To observe the application and clinical efficacy of ultrasound-guided acupotomy combined with joint mobilization surgery in the treatment of frozen shoulder. <b>Methods</b> One hundred and twenty pat...
Molecular characteristics of 14 239 patients with microsatellite instability colorectal cancer
Objective To analyze their molecular characteristics of microsatellite instability (MSI) by sequencing colorectal cancer patients in Sichuan region. Methods Next generation sequencing (NGS) was used to test 14 239 colon...